VPMCX
Price
$177.22
Change
-$0.26 (-0.15%)
Updated
Aug 19 closing price
Net Assets
71.74B
VTSMX
Price
$153.12
Change
-$0.93 (-0.60%)
Updated
Aug 19 closing price
Net Assets
1.91T
Interact to see
Advertisement

VPMCX vs VTSMX

Header iconVPMCX vs VTSMX Comparison
Open Charts VPMCX vs VTSMXBanner chart's image
Vanguard PRIMECAP I
Price$177.22
Change-$0.26 (-0.15%)
VolumeN/A
Net Assets71.74B
Vanguard Total Stock Mkt Idx I
Price$153.12
Change-$0.93 (-0.60%)
VolumeN/A
Net Assets1.91T
VPMCX vs VTSMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VPMCX vs. VTSMX commentary
Aug 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VPMCX is a Buy and VTSMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 1.91T vs. VPMCX (71.7B). VTSMX pays higher dividends than VPMCX: VTSMX (1.09) vs VPMCX (0.85). VPMCX was incepted earlier than VTSMX: VPMCX (41 years) vs VTSMX (33 years). VPMCX (0.37) is less costly to investors than VTSMX (0.14). VPMCX is a more actively managed with annual turnover of: 4.00 vs. VTSMX (2.00). VPMCX (3000) and VTSMX (3000) have matching initial minimum investment requirements. VTSMX annual gain was more profitable for investors over the last year : 16.00 vs. VPMCX (3.43). VTSMX return over 5 years is better than : 85.57 vs. VPMCX (26.60).
VPMCXVTSMXVPMCX / VTSMX
Total Expense Ratio0.370.14264%
Annual Report Gross Expense Ratio0.370.14264%
Fund Existence41 years33 years-
Gain YTD10.5049.302113%
Front LoadN/AN/A-
Min. Initial Investment30003000100%
Min. Initial Investment IRAN/AN/A-
Net Assets71.7B1.91T4%
Annual Yield % from dividends0.851.0978%
Returns for 1 year3.4316.0021%
Returns for 3 years21.4549.8943%
Returns for 5 years26.6085.5731%
Returns for 10 years79.42221.4536%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JQC5.500.01
+0.18%
Nuveen Credit Strategies Income Fund
SCHG30.730.02
+0.07%
Schwab US Large-Cap Growth ETF™
UJUL37.49N/A
N/A
Innovator U.S. Equity Ultra BffrETF™-Jul
RZB24.90N/A
N/A
Reinsurance Group of America
HRTS29.24-0.01
-0.04%
Tema Heart & Health ETF